Khairy H Morsy, Amr Zaghloul, & Magdy Mahmoud. (2019). Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?. Turkish Journal of Gastroenterology, 27(1), 55–61. Retrieved from https://tjg.avesjournals.com/index.php/tjg/article/view/3219